Gold Price Analysis: XAU/USD buyers keep $1,900 on radar amid market optimism

Gold keeps recovery moves from $1,864 despite recently easing from $1,896.

Moderna’s vaccine trials keep markets hopeful despite virus woes.

Brexit news, updates from Johnson & Johnson offer the latest positive push.

Risk catalysts to keep the driver’s seat amid a light calendar. Gold picks up bids around $1,888, up 0.07% on a day, during the early Tuesday’s Asian session. The yellow metal recently gained, after the initial $30 drop, as global markets turned optimistic on the coronavirus (COVID-19) vaccine. Also favoring the risk-on mood could be the Brexit news as well as the US dollar weakness. J&J, Moderna keeps markets upbeat… Having earlier heard that Moderna’s vaccine has a 94.5% effective rate and is easy to distribute, AP News recently came out with the headlines suggesting the start of the two-dose vaccine trials from Johnson and Johnson. Global markets are optimistic to find a […]

About the author: StockMan
Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.
Posting Guidelines
  • Do contribute something to the discussion
  • Do post factual information, analysis and your view on company valuations
  • Do disclose if you have an interest in a security
  • Do take our Terms of Use seriously
Do Not
  • Do not make low-content posts, unsubstantiated ramps or untruthful/misleading statements
  • Do not complain about a post unless you have reported it first, and not on the forum.
  • Do not post financial advice
  • Do not advertise or post sponsored content

Get involved!

Get Connected!

Come and join our community. Expand your network and get to know new people!


No comments yet